Moderna
MRNA
#290
Rank
ยฃ60.25 B
Marketcap
ยฃ148.91
Share price
-2.17%
Change (1 day)
704.40%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: ยฃ60.25 Billion

As of November 2026 Moderna has a market cap of ยฃ60.25 Billion. This makes Moderna the world's 290th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026ยฃ60.25 B565.6%
2025ยฃ9.05 B-26.44%
2024ยฃ12.30 B-58.65%
2023ยฃ29.76 B-47.82%
2022ยฃ57.03 B-25.23%
2021ยฃ76.28 B151.54%
2020ยฃ30.32 B504.16%
2019ยฃ5.01 B26.92%
2018ยฃ3.95 B

End of Day market cap according to different sources

On Nov 19th, 2026 the market cap of Moderna was reported to be:

ยฃ61.58 Billion
by Nasdaq info icon info icon
ยฃ61.58 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
ยฃ497.20 B 725.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ217.01 B 260.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
ยฃ251.73 B 317.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
ยฃ0.43 B-99.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
ยฃ2.27 B-96.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
ยฃ0.63 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ14.70 B-75.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
ยฃ4.46 B-92.59%๐Ÿ‡บ๐Ÿ‡ธ USA